Alzheimer ’s Disease Diagnostics and Patient Services Company ALZpath...

ALZpath’s pTau217 assay in blood offers a simple and cost-effective approach to diagnosis, which is less invasive than current testing methods. The ALZpath pTau217 assay is validated and available now...(PRWeb November 28, 2022)Read the full story at https://www.prweb.com/releases/alzheimers_disease_diagnostics_and_patient_services_company_alzpath_announces_novel_validated_and_scalable_assay_for_detection_of_phosphorylated_tau_217_in_blood/prweb19044296.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news